Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients (Q34622583)

3 August 2017

title

Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients (English)

1 reference

3 August 2017

1 reference

Y Zhang

1 reference

3 August 2017

S S Forootan

1 reference

3 August 2017

D Liu

1 reference

3 August 2017

R Barraclough

1 reference

3 August 2017

C S Foster

1 reference

3 August 2017

P S Rudland

1 reference

3 August 2017

Y Ke

1 reference

3 August 2017

publication date

24 April 2007

1 reference

Prostate Cancer and Prostatic Diseases

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

293-300

1 reference

Therapeutic vaccines for prostate cancer

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

The cellular and molecular basis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Molecular pathology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Prognostic significance of osteopontin expression in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Prognostic relevance of AGR2 expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Prostate-specific antigen: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

inferred from DOI database lookup

7 January 2021

based on heuristic

Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

inferred from DOI database lookup

7 January 2021

based on heuristic

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500960

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.PCAN.4500960

1 reference

3 August 2017

1 reference